Depot Disulfiram for AIDS and ARC - Full Text View

Purpose

To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.

Condition	Intervention
HIV Infections	Drug: Disulfiram

MedlinePlus related topics:

AIDS

Drug Information available for:

Disulfiram

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Open Label

Official Title:	Depot Disulfiram for AIDS and ARC

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria

Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria.

Also patient must be:
Able to understand the study.
Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms.
Ambulatory and able to maintain an independent life outside the hospital.
Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.

Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.

History of alcohol abuse.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002065

Locations


United States, New York
	Saint Vincent's Med Ctr
	Staten Island, New York, United States, 10310

Sponsors and Collaborators

St. Vincent's Medical Center

More Information

Study ID Numbers:	024A
First Received:	November 2, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00002065
Health Authority:	United States: Food and Drug Administration

Keywords provided by NIH AIDS Clinical Trials Information Service:

Delayed-Action Preparations

Disulfiram

Acquired Immunodeficiency Syndrome

AIDS-Related Complex

Study placed in the following topic categories:

Disulfiram

Virus Diseases

Sexually Transmitted Diseases, Viral

HIV Infections

Sexually Transmitted Diseases

Acquired Immunodeficiency Syndrome

AIDS-Related Complex

Retroviridae Infections

Immunologic Deficiency Syndromes

Ethanol

Additional relevant MeSH terms:

RNA Virus Infections

Slow Virus Diseases

Molecular Mechanisms of Pharmacological Action

Immune System Diseases

Therapeutic Uses

Lentivirus Infections

Enzyme Inhibitors

Infection

Central Nervous System Agents

Pharmacologic Actions

Alcohol Deterrents

ClinicalTrials.gov processed this record on December 03, 2008

Sponsored by:	St. Vincent's Medical Center
Information provided by:	NIH AIDS Clinical Trials Information Service
ClinicalTrials.gov Identifier:	NCT00002065